What volume of normal saline (0.9% sodium chloride) should be used to dilute regular human insulin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Insulin Dilution in Normal Saline

For intravenous insulin infusion, dilute regular human insulin in 0.9% normal saline to achieve concentrations between 0.1 units/mL and 1.0 units/mL 1.

Standard Dilution Protocol

The FDA-approved labeling for regular human insulin (Humulin R U-100) explicitly states that for intravenous use, insulin should be diluted in 0.9% sodium chloride using polyvinyl chloride (PVC) infusion bags at concentrations ranging from 0.1 to 1.0 units/mL 1.

Practical Dilution Examples:

  • For 0.1 units/mL concentration: Add 10 units of insulin to 100 mL of 0.9% NS (yields 100 mL total)
  • For 1.0 units/mL concentration: Add 100 units of insulin to 100 mL of 0.9% NS (yields 100 mL total)

Clinical Context Applications

For DKA/HHS Management:

Current ADA guidelines recommend fixed-rate IV insulin infusions for diabetic ketoacidosis and hyperosmolar hyperglycemic state, with insulin administered alongside 0.9% NaCl or other crystalloids 2. The standard approach uses:

  • 0.1 units/kg/h for moderate-to-severe DKA
  • 0.05 units/kg/h for HHS or mild DKA

For High-Dose Insulin Therapy:

When treating severe calcium channel blocker or beta blocker toxicity requiring high-dose insulin, more concentrated solutions are stable and appropriate. Research demonstrates that 16 units/mL concentration in 0.9% NS remains stable for 14 days when stored either refrigerated or at room temperature 3. This higher concentration prevents fluid overload during prolonged high-dose insulin infusions.

Stability Considerations

Prepared insulin solutions in 0.9% NS are stable for 48 hours refrigerated, then an additional 48 hours at room temperature 1. For extended storage, regular human insulin at 1 unit/mL in PVC bags maintains >90% potency for up to 336 hours (14 days) when refrigerated at 2-8°C 4.

Critical Safety Points

  • Always use PVC infusion bags as specified in FDA labeling 1
  • Inspect visually before administration—solution must be clear and colorless; never use if viscous or cloudy 1
  • Monitor closely for hypoglycemia and hypokalemia during IV insulin administration 1
  • The dilution concentration affects neither the pharmacologic onset (10-15 minutes IV) nor duration (median 4 hours) 1

Common Pitfalls to Avoid

  • Do not exceed 1.0 units/mL for standard hospital protocols unless specifically treating toxicologic emergencies requiring high-dose insulin
  • Do not use concentrations below 0.1 units/mL as this falls outside FDA-approved parameters
  • Do not mix insulin with solutions other than 0.9% sodium chloride for IV administration
  • Do not use expired insulin or insulin that has been frozen

Related Questions

How should insulin and dextrose be managed in a hyperosmolar hyperglycemic state patient whose blood glucose is 156 mg/dL?
What is an emergency checklist for diagnosing and managing hyperosmolar hyperglycemic state, including glucose and serum osmolarity criteria, fluid resuscitation, potassium replacement, insulin titration, monitoring frequency, and precautions according to British Diabetes Society guidelines?
In an 84-year-old female with a blood glucose of 699 mg/dL, bicarbonate 19 mmol/L, anion gap 15, venous pH 7.40, serum osmolality 301 mOsm/kg, and beta‑hydroxybutyrate 0.33 mmol/L, does she meet criteria for hyperosmolar hyperglycemic state?
In a patient with hyperosmolar hyperglycemic state whose glucose decreased from 33 mmol/L to 22 mmol/L after receiving 0.9% normal saline at 1 L/hour for 2 hours, with serum sodium unchanged at 132 mEq/L, what is the most appropriate next step in fluid management?
What laboratory findings characterize the hyperosmolar hyperglycemic state?
What is the maximum recommended daily dose of ropinirole for Parkinson's disease and for restless‑legs syndrome?
What is the recommended dose of acebrophylline for adults and children?
How do flecainide and sotalol compare with beta‑blockers and calcium channel blockers for rhythm versus rate control in atrial fibrillation?
What is occupational health screening for workers, when and why is it performed, how can the authenticity of an excuse‑duty (sick‑leave) form be verified, what defines child abuse and its types, and what steps should be taken when a child presents with suspicious burn injuries or signs of malnutrition?
After a cholecystectomy, why does fat digestion continue despite continuous bile flow into the duodenum, and when would pancreatic enzyme supplementation or other medications be necessary?
What is the appropriate diagnosis for a patient with known bipolar disorder who is currently experiencing severe depression with suicidal ideation, no auditory or visual hallucinations, and whose last manic episode occurred over a year ago?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.